患者特异性一体式分支开窗覆膜支架用于复杂主动脉瘤腔内修复的早期经验
本研究回顾了两个机构34个月内连续接受一体式分支开窗患者特异性厂商定制器械(PS-CMD)行复杂EVAR的33例患者,技术成功率100%,中位随访11.7个月靶血管一期通畅率100%,2例因髂动脉闭塞再干预,无主动脉相关死亡。作者认为该器械是肾动脉与主动脉分叉间距离短患者的简单、安全、经济替代方案,但需进一步研究评估获益与耐久性。
要点
- 33例复杂EVAR患者使用一体式分支开窗PS-CMD,技术成功率100%。
- 中位随访11.7个月靶血管一期通畅率100%,无主动脉相关死亡。
- 2例(6.06%)因髂动脉闭塞再干预,1例Ib内漏经腿延伸治疗。
核心结论
- 复杂EVAR使用一体式分支开窗PS-CMD是治疗肾动脉与主动脉分叉间距离短患者的简单、安全、经济替代方案。
- 需进一步研究评估一体式分支开窗器械的获益与耐久性。
研究设计与样本
- 回顾两个机构34个月内连续复杂EVAR手术,使用一体式分支开窗器械作为医师发起的研究性器械豁免研究的一部分。
- 共168例患者接受复杂EVAR,其中33例(19.6%)接受一体式分支开窗PS-CMD。
主要发现
- 33例中男性78.7%,平均年龄77岁,中位最大动脉瘤直径61 mm(IQR 55-69 mm)。
- 29例(87.9%)有既往EVAR史,其中2例(6.06%)有肾上支架;30例(90.9%)显示肾动脉与主动脉分叉间距离短,中位距离47 mm(IQR 38-54 mm)。
- 技术成功率100%,中位随访11.7个月(IQR 3.5-18.6个月)靶血管一期通畅率100%。
- 2例(6.06%)因髂动脉闭塞再干预(1例支架置入,1例股股旁路),无主动脉相关死亡。
- 随访检出11例II型内漏(33.3%)和1例Ib型内漏(3.03%),后者经腿延伸治疗;无Ia或III型内漏。
局限性
- 需进一步研究评估一体式分支开窗器械的获益与耐久性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Short distances between the lowest visceral/renal artery and the aortic bifurcation are technically challenging during complex endovascular aortic aneurysm repair (EVAR), particularly after previous infrarenal repair. Traditionally, inverted limb bifurcated devices have been used in addition to fenestrated-branched (FB) endografts, but short overlap, difficult cannulation, and potential crushing of bridging stents are limitations for their use. This study reviews the early experience of patient-specific company manufactured devices (PS-CMDs) with a unibody bifurcated FB design for complex EVAR. METHODS: Consecutive complex EVAR procedures over a 34-month period with unibody bifurcated FB-devices as part of physician-sponsored investigational device exemption studies at two institutions were reviewed. Unibody bifurcated FB designs included FB bifurcated or fenestrated inverted limb devices. End points included technical success, survival, frequency of type I or III endoleaks, limb occlusion, and secondary interventions. RESULTS: Among 168 patients undergoing complex EVAR, 33 patients (19.6%; 78.7% male; mean age, 77 years) received unibody bifurcated FB PS-CMDs. FB bifurcated and fenestrated inverted limb devices were used in 31 (93.9%) and 2 (6.06%) patients, respectively. The median maximum aneurysm diameter was 61 mm (interquartile range [IQR], 55-69 mm). Prior EVAR was reported by 29 patients (87.9%), of whom 2 (6.06%) had suprarenal stents. A short distance between the lowest renal artery and aortic bifurcation was demonstrated in 30 patients (90.9%), with median distance of 47 mm (IQR, 38-54 mm). Preloaded devices were used in 23 patients (69.7%). A total of 128 fenestrations were planned; 22 (17.2%) were preloaded with guidewires and 5 (3.9%) with catheters. The median operative time was 238 minutes (226-300 minutes), with a median fluoroscopy time of 65.5 minutes (IQR, 56.0-77.7 minutes) and a median dose area product of 147 mGy∗cm2 (IQR, 105-194 mGy∗cm2). Exclusive femoral access was used in 14 procedures (42.4%). Technical success was 100%. Target vessel primary patency was 100% at a median follow-up time of 11.7 months (IQR, 3.5-18.6 months). Two patients (6.06%) required reintervention for iliac occlusion; one patient required stenting and the other a femoral-femoral bypass. No aortic-related deaths occurred after the procedure. During follow-up, 11 type II endoleaks (33.3%) and 1 type Ib endoleak (3.03%) were detected; the latter was treated with leg extension. No type Ia or III endoleaks occurred. CONCLUSIONS: Complex EVAR using unibody bifurcated FB-PS-CMDs is a simple, safe, and cost-effective alternative for the treatment of patients with short distances between the renal arteries and the aortic bifurcation. Further studies are required to assess benefits and durability of unibody bifurcated FB devices.
引用
- Tanenbaum MT, Figueroa AV, Kanamori LR, et al. Early experience with patient-specific unibody bifurcated fenestrated-branched devices for complex endovascular aortic aneurysm repair. J Vasc Surg. 2024. PMID: 38897392. doi:10.1016/j.jvs.2024.06.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。